8 March 2022 - Written by Philip Turton

1965 is the Watershed: Watt v Lend Lease Construction (Europe) Ltd

Philip Turton considers the decision of Lord Uist in the Scottish mesothelioma case of Watt v Lend Lease Construction (Europe) Ltd [2022] CSOH 23, an interesting decision from north of the border (judgment ...

Read more

20 January 2022 - Written by Jonathan Owen & Jessica Woodliffe

Court of Appeal Rejects Insurers' Challenge to CRU Scheme

On 14 January 2022, the Court of Appeal handed down judgment in Aviva Insurance Ltd & Anor v Secretary of State for Work and Pensions [2022] E...

Read more

9 November 2021 - Written by Philip Turton

Oh Flower of Scotland... Haggerty-Garton v ICI [2021] EWHC 2924 (QB)

On 3 November 2021 the newly appointed Ritchie J handed down his judgment in Haggerty-Garton v ICI [2021] EWHC 2924 (QB), a mesothelioma case brought in the High Court but, pursuant to a consent order agreed between the First Claimant and the Defendant, ...

Read more

13 September 2021 - Written by Philip Godfrey

SURPRISE! Now, Show Cause!

On 27 July 2021, the Court of Appeal handed down judgment in Ministry of Defence v Sivaji [2021] EWCA Civ 1163 which addresses the procedural rules f...

Read more

22 June 2021 - Written by Nikhil Arora

Success Fees in Mesothelioma Cases: Moutarde v SIG Logistics

In this blog, Nik Arora reviews the decision in Moutarde v SIG Logistics to limit the Claimant's success fee in a mesothelioma claim to 27.5%. Q. When is a trial not a trial? ...

Read more

17 May 2021 - Written by Richard Gregory

Non-Party Disclosure and CPR 31.17: Sparkes v London Pension Funds Authority & Leigh Academies Trust

A good month for claimants in historic asbestos claims continues. Coming shortly after Scarborough College Ltd v Winter [2021] EWHC 1549 (QB), in which a Show Cause finding in a claimant’s favour was undisturbed on appeal (...

Read more

6 May 2021 - Written by Philip Godfrey & Alexandra Pountney

Scarborough College v Winter: Spotlight on the Show Cause Procedure

In Scarborough College Ltd v Winter [2021] EWHC 1549 (QB), the High Court considered an appeal by a Defendant against the decision of a Master to enter judgment under CPR PD3D (the show cause procedure). The appeal was dismissed. Cavanagh J held that Jud...

Read more

19 January 2021 - Written by Thomas Herbert

Court of Appeal Considers 'Lost Years' Claims in Head v The Culver Heating Co Ltd

In a judgment handed down on 18 January 2021 in Head v The Culver Heating Co Ltd [2021] EWCA Civ 34, the Court of Appeal unanimously allowed an appeal against the decision of HHJ Melissa Clarke dismissing the Claimant's 'lost years' claim. The judge had dismi...

Read more

18 January 2021 - Written by Jessica Woodliffe

Latest Instalment in Insurers' Challenge to CRU Provisions

In R (on the application of (1) Aviva Insurance Ltd (2) Swiss Reinsurance Company Ltd) v The Secretary of State for Work and Pensions [2021] EWHC 30 (Admin), Henshaw J dealt with certain consequential matters arising from his ...

Read more

14 December 2020 - Written by Abigail Scott

IIAC Announces Review of the Relationship Between Respiratory Diseases and Occupational Exposures

The Industrial Injuries Advisory Council (IIAC) has announced its intention to conduct a review of selected malignant and non-malignant respiratory diseases and their relationships with occupational exposures. The IIAC is the advis...

Read more

30 November 2020 - Written by Jessica Woodliffe

Certain Compensation Recovery Unit Payments Declared Incompatible with the European Convention on Human Rights

In R (on the application of (1) Aviva Insurance Ltd (2) Swiss Reinsurance Company Ltd) v The Secretary of State for Work and Pensions [2020] EWHC 3118 (Admin), the Claimants challenged the unintended and onerous consequences of the Compensation Recovery Unit ...

Read more

23 October 2020

Ropewalk Chambers One of Only Four Sets Ranked for Industrial Disease in Chambers & Partners 2021

Following our recent success in the Legal 500 2021, Chambers' expertise in the field of industrial dis...

Read more

3 October 2020 - Written by Philip Turton

Nivolumab and Ipilimumab Approved as Immunotherapy Treatments in the USA

On 2 October 2020, the American Food & Drug Administration approved a combination of nivolumab (OPDIVO, Bristol-Myers Squibb Co) and ipilimumab (YERVOY, Bristol-Myers Squibb Co) as a first-line treatment for adults with unresectable mesothelioma. Randomi...

Read more

Ropewalk Chambers

Ropewalk Chambers has, over many decades, established a market-leading reputation for detailed and specialist expertise in the field of Industrial Disease litigation.

Whether asbestos, noise, dust, vibration, stress or any other insidious process, including those which are newly emerging, its members have consistently appeared in the leading cases, determining the limits of liability, causation and quantum at first instance and appellate level.

Work is distributed within Chambers to enable Members of Chambers to represent both Claimants and Defendants in this field.

To find out more about our Disease barristers, click here.

Search blog by title or barrister

Subscribe for blog updates

We’re fully committed to handling personal information you’ve supplied to us in compliance with the latest GDPR laws, and we’ll never share your details. If you wish to unsubscribe, please click here to update your data preferences at any time.

Search by keyword

Recent Posts

Archive